> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 2 EUAs Revoked on Covid-19 Tests
- URL: https://www.fdaweb.com/2-euas-revoked-on-covid-19-tests/
- Published: 2022-03-07T12:00:00.000Z
- Updated: 2026-09-14T17:35:28.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151301

*Federal Register* notice: FDA has revoked the Emergency Use Authorizations (EUAs) issued to Bio-Rad Laboratories for the BioPlex 2200SARS–CoV–2 IgG, and Quotient Suisse SA for the MosaiQ Covid–19 Antibody Magazine. The agency revoked EUA for the BioPlex device because it was never commercialized, and the EUA for the MosaiQ device because it is no longer being commercially supported. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-03-04/pdf/2022-04635.pdf?ref=fdaweb.com).